Jump to Main Content
Dephosphorylation of Girdin by PP2A inhibits breast cancer metastasis
- Li, Jiang, Enomoto, Atsushi, Weng, Liang, Sun, Lunquan, Takahashi, Masahide
- Biochemical and biophysical research communications 2019 v.513 no.1 pp. 28-34
- breast neoplasms, cell movement, dephosphorylation, humans, lymph nodes, metastasis, neoplasm cells, phosphoprotein phosphatase, phosphorylation, serine
- Dysfunction of Girdin plays a crucial role in the development of a variety of tumors. Phosphorylated regulation of Girdin has been studied extensively. However, how Girdin is dephosphorylated remains unclear. In this study, we report a mechanism of Girdin dephosphorylation and the importance of this mechanism in the migration of breast cancer cells. We show that the protein phosphatase 2A (PP2A) complex can bind to Girdin via the modulating B subunit. Overexpression or knockdown of PP2A inhibits or increases the phosphorylation of Girdin at serine 1416, respectively. PP2Ac-induced Girdin dephosphorylation is involved in the inhibition of breast cancer cell migration. Furthermore, in human breast cancer samples, PP2Ac expression is negatively correlated with the phosphorylation of Girdin, and low expression of PP2Ac is correlated with tumor stage, grade and lymph node metastasis of breast cancer. These data indicate that PP2A regulates Girdin dephosphorylation and highlight the critical role of this pathway in breast cancer metastasis.